Author:
Naveen Sadhu M,Sivanandhan Dhanalakshmi,Gajendran Chandru,Tantry Subramanyam,Dewang Purushottam,Murugan Kannan,Chickamunivenkatappa Srinatha,Zainuddin Mohd,Nair Sreekala,Vaithilingam Krishnakumar,Rajagopal Sridharan
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference32 articles.
1. Natural products as LSD1 inhibitors for cancer therapy;Fang;Acta Pharm Sinica B,2020
2. Advances toward LSD1 inhibitors for cancer therapy;Fu;Future Med Chem,2017
3. LSD1/KDM1A inhibitors in clinical trials: advances and prospects;Fang;J Hematol Oncol,2019
4. ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of acute leukemia;Maes;Cancer Cell,2018
5. Phase I, open-label, dose-escalation study of the safety, pharmacokinetics, pharmacodynamics, and efficacy of GSK2879552 in relapsed/refractory SCLC;Bauer;J Thoracic Oncol,2019
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献